Revenue
91.3 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 91306000 USD Source
Market value
$913.2M
62,037,725 shares as of 2026-11-03, at $14.72 a share (OMDA, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 260.2M, using the latest reported figures. The previous period, 2024, was about USD 169.8M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-17.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
91.3 million USD
2026 Q3 · USD
5.28%
2026 Q3 · %
15.1 million USD
2026 Q3 · USD
15 million USD
2026 Q3 · USD
243151000 USD
61996000 shares
7.10% · 4.11 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
333 million USD
2025-10-01 – 2026-09-30
14 million USD
2025-10-01 – 2026-09-30
28.7 million USD
2025-10-01 – 2026-09-30
541 thousand USD
2025-10-01 – 2026-09-30
28.2 million USD
2025-10-01 – 2026-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-06.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 169.8 million
–
Current period
USD 260.21 million
–
260210000 − 169800000 = 90410000 USD
169800000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source260210000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 47.14 million
–
Current period
−USD 12.78 million
–
-12778000 − -47137000 = 34359000 USD
-47137000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-12778000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 34.18 million
–
Current period
USD 18.25 million
–
18252000 − -34179000 = 52431000 USD
-34179000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source18252000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 596,000
–
Current period
USD 1.32 million
–
1322000 − 596000 = 726000 USD
596000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1322000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 122784000 | 188781000 Derived | -65997000 | 1514000 Derived | -67511000 | -50154000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 169800000 | 213454000 Derived | -43654000 | 3483000 Derived | -47137000 | -34775000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 260210000 | 272182000 Derived | -11972000 | 806000 Derived | -12778000 | 16930000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 122784000 |
|
| 2024 | Revenue | 169800000 |
|
| 2025 | Revenue | 260210000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 38.3% |
|
| 2025 | Year over year | 53.2% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -53.8% |
|
| 2024 | Operating margin | -25.7% |
|
| 2025 | Operating margin | -4.6% |
|
| 2023 | Net margin | -55% |
|
| 2024 | Net margin | -27.8% |
|
| 2025 | Net margin | -4.9% |
|
| 2023 | Free cash flow margin | -40.8% |
|
| 2024 | Free cash flow margin | -20.5% |
|
| 2025 | Free cash flow margin | 6.5% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -49738000 |
|
| 2024 | Operating cash flow | -34179000 |
|
| 2025 | Operating cash flow | 18252000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -50154000 |
|
| 2024 | Free cash flow | -34775000 |
|
| 2025 | Free cash flow | 16930000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2024 | Liabilities / assets | 57.2% |
|
| 2025 | Liabilities / assets | 24.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024 | Current assets / current liabilities | 2.1× |
|
| 2025 | Current assets / current liabilities | 3.6× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | −USD 67.51 million Exact valueExact value: -67511000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49.74 million Exact valueExact value: -49738000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 416,000 Exact valueExact value: 416000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 50.15 million Calculation and evidence-49738000 − 416000 USD Exact free cash flow: -50154000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 47.14 million Exact valueExact value: -47137000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 34.18 million Exact valueExact value: -34179000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 596,000 Exact valueExact value: 596000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 34.78 million Calculation and evidence-34179000 − 596000 USD Exact free cash flow: -34775000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 12.78 million Exact valueExact value: -12778000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 18.25 million Exact valueExact value: 18252000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.32 million Exact valueExact value: 1322000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 16.93 million Calculation and evidence18252000 − 1322000 USD Exact free cash flow: 16930000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
9 filings · 850 latest values · 850 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001611115, 1611115, OMDA, edgar:1611115
Also known as Omada Health, Inc.